Brief: Zivo Bioscience Has Received Notice Of Delisting From Nasdaq
29/11/2022 21:43
Nov 29 (Reuters) - Zivo Bioscience Inc ZIVO.O :
* ON NOVEMBER 22, 2022, CO RECEIVED NOTICE OF DELISTING OR
FAILURE
TO SATISFY A CONTINUED LISTING RULE OR STANDARD FROM NASDAQ
Further company coverage: ZIVO.O
((Reuters.Briefs@thomsonreuters.com))
Recent news on Zivo Bioscience
See all newsBrief: Zivo Bioscience Plans New Study With University Of Delaware To Combat Avian Influenza In Poultry
Brief: Zivo Bioscience Reports Preliminary Efficacy Of Its Proprietary Active Ingredients In Battle Against Avian Influenza
Brief: Zivo Bioscience Initiates 42-Day Validation Study With Immune-Modulating Product
Brief: Zivo Bioscience Announces Reverse Stock Split
Brief: Trial Results Confirm Efficacy Of Zivo Bioscience’S Non-Antibiotic Product Candidate For The Prevention And Treatment Of Coccidiosis In Broiler Chickens